The nonprofit preclearance agency that reviews drug advertising directed to healthcare professionals to ensure adherence with the regulatory framework
Pickering, Ontario
Joined June 2009
- Tweets142
- Following38
- Followers286
- Likes19
New advisory on Exclusivity Claims for Indications is now posted. Read the complete advisory on an expanded approach to exclusivity claims ow.ly/ZM7g50My19I .
PAAB is excited to announce that our first RWE Committee meeting will be kicking off November 28th! #Pharmamarketing #PAAB #RWE
Just under a week to go for the PAAB ARO Q&A Virtual Session. We'll be answering all your questions on the launch of ARO and the new Submissions Guidance. List of resources and link to register at paab.ca/resources/aro-submis…
Registration is open for PAAB's Virtual ARO Q&A Session. Find a link along with a list of documents to familiarize yourself with prior to the session at paab.ca/resources/aro-submis…
ALT Register for the PAAB Virtual ARO Q&A Session May 18th. PAAB staff will be live for 1 hour to answer your questions about the upcoming implementation of ARO including, submission requirements, submission formats, guidance documents and the fee calculator. Registration link: https://us02web.zoom.us/webinar/register/3616515311412/WN_EpGVidE7RgCEgODrsvwaRQ
See how PAAB is preparing for the launch of ARO and make sure not to miss any key resources that will be available to help facilitate a smooth transition to new submission practices in video 4 of 4 in the Submissions Process and Features series. paab.ca/resources/submission…
The Fee Calculator has gone live on the PAAB.ca homepage (top right corner). See a quick overview of the new and revised fee structures to address the various levels of urgency and submission types before you get started. paab.ca/resources/submission…
Learn about modular and iterative submissions, variable field options and other new features available soon. paab.ca/resources/submission…
The new submission guidance document is almost done. Prime yourself with what you can expect from the new submission options with a quick introductory video on the Accelerated Review Options (ARO) paab.ca/resources/submission…
Looking for more guidance on creating compliant small space ads like rotating banner ads, leaderboards, small squares and more?
Read up on the NEW PAAB Advisory – Small Space Ads ow.ly/S0EC50IpapZ #marketing #Pharmaceuticals #bannerads
NEW Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising is now posted and will come into effect on April 18th. Read the full guidance here: ow.ly/sWyk50IojeN #Guidance #pharmamarketing #advertising
STOP and look for the PAAB logo – the Health Canada recognized APA for healthcare professional drug advertising.
Tackling the Illegal Marketing of Drugs and Devices pharmacyconnection.ca/tackli… #pharmacists #marketing #drugadvertising Article from the @OCPInfo
People are talking about PAAB's Accelerated Review Options (ARO) change coming in July! smartbiggar.ca/insights/publ…
All 4 quarters of the Tag Report for 2021 are now live on the PAAB website. Check out the quarterly trends at paab.ca/resources/paab-tag-r… and let us know what else you'd like to know.
Planning for 2022? Did you know the AROs Features Document includes the fee schedule to take effect as of July 2022? paab.ca/resources/coming-soo…
Did you know the Accelerated Review Options (AROs) features document includes info on MODULAR and ITERATIVE submissions? Learn more at ow.ly/tMtw50H4uKc
Project AROs (Accelerated Review Options) Planned Features Document is now live!
Head on over to paab.ca/resources.htm to learn more!
We’ve posted the Q1 and Q2 Tag report. This document will be updated quarterly with a full report at the end of the year. Learn more at PAAB.ca/resources
The PAAB will be closed on September 30, 2021 in observance of the National Day for Truth and Reconciliation. Join us in reflecting on our history and the role we can all play in shaping a future which is free of structural racism. We reopen for business ...